Vous avez cherché: kelatorji (Slovène - Anglais)

kelatorji Železa
iron chelators

sočasna uporaba z drugimi kelatorji železa
combined use with other iron chelators

prilagoditve odmerka pri uporabi z drugimi kelatorji železa
dose adjustments when used with other iron chelators

zdravilo se ne sme uporabljati v kombinaciji z drugimi kelatorji železa.
it must not be used in combination with other iron chelators.

varnost uporabe deferasiroksa v kombinaciji z drugimi kelatorji železa ni bila ugotovljena.
the safety of deferasirox in combination with other iron chelators has not been established.

farmakoterapevtska skupina: kelatorji železa, oznaka atc: v03ac03 mehanizem delovanja
pharmacotherapeutic group: iron chelating agents, atc code: v03ac03 mechanism of action

kelatorji edta (etilendinitrilotetraocetna kislina ali etilendiamintetraocetna kilsina) in dtpa dietilentriaminopentaocetna kislina).
the chelators edta (ethylenedinitrilotetraacetic acid or ethylenediaminetetraacetic acid) and dtpa diethylenetriaminopentaacetic acid).

raven bakra v urinu se pri zdravljenju s kelatorji, na primer s penicilaminom ali trientinom, navadno zviša.
urinary copper levels are usually increased with chelation therapy such as penicillamine or trientine.

zato se ga ne sme uporabljati v kombinaciji z drugimi kelatorji železa (glejte poglavje 4.3).
therefore, it must not be combined with other iron chelator therapies (see section 4.3).

izločanje bakra z urinom je natančen odsev obremenitve telesa z odvečnim bakrom samo takrat, ko se bolniki ne zdravijo s kelatorji.
the urinary excretion of copper is an accurate reflection of body loading with excess copper only when patients are not on chelation therapy.

kombinacija zdravljenja z drugimi kelatorji železa, saj varnost takih kombinacij ni bila ugotovljena (glejte poglavje 4.5).
combination with other iron chelator therapies as the safety of such combinations has not been established (see section 4.5).

ti kelatorji zavirajo radiotoksičnost itrija z izmenjavo kalcijevega iona in itrija zaradi svoje sposobnosti tvorbe vodotopnih kompleksov s kelacijo ligandov (dtpa, edta).
these chelating agents suppress yttrium radiotoxicity by an exchange between the calcium ion and the yttrium due to their capacity of forming water soluble complexes with the chelating ligands (dtpa, edta).

ti kelatorji pomagajo pri zaviranju radiotoksičnosti lutecija (177lu) z izmenjavo med kalcijevim ionom v kompleksu in lutecijevim (177lu) ionom.
these chelating agents help with the elimination of lutetium (177lu) radiotoxicity by an exchange between the calcium ion in the complex and the lutetium (177lu) ion.

ti kelatorji zavirajo radiotoksičnost bakra z izmenjavo med kalcijevimi ioni in bakrom na podlagi zmožnosti bakra, da z ligandi za kelatiranje (dtpa, edta) tvori v vodi topne komplekse.
these chelating agents help elimination of copper radiotoxicity by an exchange between the calcium ion and the copper due to their capacity of forming water soluble complexes with the chelating ligands (dtpa, edta).

ti kelatorji zavirajo radiotoksičnost itrija z izmenjavo kalcijevih ionov in itrija, na podlagi zmožnosti itrija, da z ligandi za kelatiranje (dtpa, edta) tvori v vodi topne komplekse.
these chelating agents suppress yttrium radiotoxicity by an exchange between the calcium ion and the yttrium due to their capacity of forming water soluble complexes with the chelating ligands (dtpa, edta).

kadar bolniku, ki se zdravi s kelatorji, zamenjujemo kelatorje z wilzinom za vzdrževalno zdravljenje, je treba zdravljenje s kelatorji vzdrževati in nadaljevati skupaj z wilzinom še 2 do 3 tedne, ker toliko časa traja, da zdravljenje s cinkom povzroči maksimalno indukcijo metalotioneina in popolno blokado absorpcije bakra.
when switching a patient on chelating treatment to wilzin for maintenance therapy, the chelating treatment should be maintained and co-administered for 2 to 3 weeks since this is the time it takes for the zinc treatment to induce maximum metallothionein induction and full blockade of copper absorption.